Retinobenzoic acids. 3. Structure-Activity Relationships of retinoidal Azobenzene-4-carboxylic acids and Stilbene-4-carboxylic acids by H. Kagechika et al., Journal of Medicinal Chemistry, 1989, 32, pp. 1098-1108. |
A General Synthesis of Terminal and Internal Arylalkynes by the Palladium-Catalyzed Reaction of Alkynylzinc Reagents with Aryl Halides by Anthony O. King and Ei-ichi Negishi, J. Org. Chem. 43 No. 2, 1978. |
Conversion of Methyl Ketones into Terminal Acetylenes and (E)-Trisubstituted Olefins of Terpenoid Origin by egishi, Anthony O. King, and William L. Klima, J. Org. Chem. 45 No. 12, 1980 p. 2526. |
A Convenient Synthesis of Ethynylarenes and Diethynylarenes by S. Takahashi, Y. Kuroyama, K. Sonogashira, N. Hagihara, Synthesis 1980 p. 627-630. |
Sporn et. al. in J. Amer. Acad. Derm. 15:756-764 (1986). |
Shudo et al. in Chem. Phar. Bull. 33:404-407 (1985). |
Pemrick et al., PubMed Abstract (Leukemia, 8 Suppl 3:S1-10), 1994. |
Mehta et al., Involvement of Retinoic Acid Receptor—alpha- Mediated Signaling Pathway in Induction of CD38 Cell-Surface Antigen, Blood, vol. 89, No. 10, pp. 3607-3614, 1997. |
Miller et al., The Emerging Role of Retinoids and Retinoic Acid Metabolism Blocking Agents in the Treatment of Cancer, Cancer (ACS), vol. 83, No. 8, pp. 1471-1482, 1998. |
Chandraratna, PubMed Abstract (Cutis, 61(2 Suppl): 40-5), 1998. |
Kagechika et. al. in J. Med. Chem. 31:2182-2192 (1988). |
Davis et al. J. Organomettalic Chem 387 (1990) 381-390. |
Chemistry and Biology of Synthetic Retinoids by Marcia I. Dawson and William H. Okamura, published by CRC Press Inc., 1990, p. 334-335, 354. |
Synthesis of 2,2′-Diacyl-1,1′-biaryls. Regiocontrolled Protection of . . . by Mervic, et al., J. Org. Chem., No. 45, p. 4720-4725, 1980. |
A Dopamine Receptor Model and Its Application in the Design of a New Class of Rigid Pyrrolo[2,3-g] isoquinoline Antipsychotics, Gary L. Olson, et al. American Chemical Society, 1981, vol. 24, No. 9, pp. 1026-1031. |
6.2.3 Conformational Restriction Williams, et al., Drug Discovery and Development, 1987 The Humana Press,pp. 54-55. |
V. Retinoid Structure-Biological Activity Relationships,Chemistry and Biology of Synthetic Retinoids, pp. 324-356, 1990. |
Effects of 13-Cis-Retinoic Acid, All-Trans-Retinoic Acid, and Acitretin on the Proliferation, Lipid Synthesis and Keratin Expression of Cultured Human Sebocytes In Vitro, C.C. Zouboulis, The Journal of Investigative Dermatology, vol. 96, No. 5, May 1991, pp. 792-797. |
Organ maintenance of human sebaceous glands: in vitro effects of 13-cis retinoic acid and testosterone, John Ridden, et al., Journal of Cell Science, vol. 95, 1990, pp. 125-136. |
Characterization of Human Sebaceous Cells In Vitro, Thomas I. Doran, et al., The Journal of Investigative Dermatology, vol. 96, No. 3, Mar. 1991. |
Synthesis and Evaluation of Stilbene and Dihydrostilbene Derivatives as Potential Anticancer Agents That Inhibit Tubulin Polymerization by Cushman, Mark, et al., J. Med. Chem., 1991, 34, 2579-2588. |
Synthesis and Evaluation of New Protein-Tyrosine Kinase Inhibitors. Part 1. Pyridine-Containing Stilbenes and Amides by Cushman, Mark et al. Bioorganic & Medicinal Chemistry Letters, vol. 1, No. 4, pp. 211-214, 1991. |
Di- and Tri-methoxystyryl Derivatives of Heterocyclic Nitrogen Compounds, by Bahner, C.T. et al., Arzneim-Forsch/Drug Res., 31, (I), Nr. 3 (1981). |
Eyrolles, L. et al. “Retinoid Antagonists: Molecular Design Based on the Ligand Superfamily Concept” Med. Chem. Res (1992) 2:361-367. |
Liu, S.S. et al. “Systemic Pharmacokinetics of Acetylenic Retinoids in Rats”, Drug Metabolism and Disposition, (1990) 18/6:1071-1077. |
Chemical Abstracts, vol. 122, No. 13,Mar. 27, 1995 abstract No. 151372m, (S. Kaku et al.). |
Chemical Abstracts, vol. 117, No. 13, Sep. 28, 1992 abstract No. 12409j, (S. Sun et al.). |
European Journal of Biochemistry, vol. 212, No. 1, 1993, Berlin, pp. 13-26, XP000618300 (S. Keidel et al.). |
Journal Of Medicinal Chemistry, vol. 39, No. 16, Aug. 2, 1996, pp. 3035-3038, Min Teng et al. |
Journal Of Medicinal Chemistry, vol. 37, No. 10, May 13, 1994, pp. 1508-1517, Laurence Eyrolles. |
Biochemical And Biophysical Research Communications, vol. 155 No. 1, 1988, pp. 503-508. |
Journal Of Medicinal Chemistry, vol. 38, No. 16, Aug. 4, 1995, pp. 3163-3173. |
Mangelesdorf, et al. “The Retinoid Receptors”, Biology, Chemistry and Medicine, 2nd Ed. Chapter 8, pp. 319-349. |
Nagpal, et al., “Negative Regulation of Two Hyperproliferative Keratinocyte Differentiation Markers by a Retinoic Acid Receptor-specific Retinoid: Insight into the Mechanism of Retinoid Action in Psoriasis,” Cell Growth & Differentiation, vol. 7 (Dec. 1996), pp .1783-1791. |
Horlein, et al., “Ligand-independent repressing by the thyroid hormone receptor medicated by a nuclear receptor co-repressor,” Letters to Nature, vol. 377 (Oct. 5, 1995), pp 397-404. |
Weiner, et al., “A phase I trial of topically applied trans -retinoic acid in cervical dysplasia-clinical efficacy”, Investigational New Drugs, 4:241-244, 1996. |
Ishikawa, et al., “A Functional Retinoic Acid Receptor Encoded by the Gene on Human Chromosome 12”, Molecular Endocrinology, vol. 4 No. 6 (1990), pp. 837-844. |
Jones, et al., “A dose-response study of 13-cis-retinoic acid in acne vulgaris”, British Journal of Dermatology, (1983) 108, 333-343. |
Sen, et al., “The Role of Breakdown of the Blood-Retinal Barrier in Cell-Injection Models of Proliferative Vitreoretinopathy”, Arch Ophthalmol, vol. 106 (Sep. 1988), pp. 1291-1294. |
Peck, et al., “Prolonged Remissions of Cystic and Conglobate Acne with 13-CIS-Retinoic Acid,” The New England Journal of Medicine, vol. 300 No. 7 (Feb. 15, 1979), pp .329-333. |
Araiz, et al., “Antiproliferative Effect of Retinoic Acid in Intravitreous Silicone Oil in an Animal Model of Proliferative Vitreoretinopathy”, Investigative Ophthalmology & Visual Science, vol. 34, No. 3 (Mar. 1993), pp. 522-530). |
Benbrook, et al., “A new retinoic acid receptor identified from a hepatocellular carcinoma”, Letters to Nature, vol. 333, No. 16 (Jun. 1988), pp. 669-672. |
Giguere, et al., “Identification of a receptor for the morphogen retinoic acid”, Letters to Nature, vol. 330 17 (Dec. 1987), pp. 624-629. |
de Wet, et al., “Firefly Luciferase Gene: Structure and Expression in Mammalian Cells”, Molecular and Cellular Biology, vol. 7 No. 2 (Feb. 1987). |
Matrisian, et al., “Isolation of the Oncogene and Epidermal Growth Factor-Induced Transin Gene: Complex Control in Rat Fibroblasts,” Molecular and Cellular Biology, vol. 6, No. 5 (May 1986). |
Madsen, et al., “Molecular Cloning and Expression of a Novel Keratinocyte Protein v(Psoriasis-associated fatty acid-binding protein [PA-FABP]) that is Highly Up-Regulated in Psoriatic Skin and that Shares Similarity to Fatty Acid-Binding Proteins”, The Journal of Investigative Dermatology, vol. 99, No. 3 (Sep. 1992), pp. 299-305. |
Fekrat, et al., “The Effect of Oral 13-cis-retinoic Acid on Retinal Redetachment after Surgical Repair in Eyes with Proliferative Vitreoretinopathy”, Opthalmology, vol. 102, No. 3 (Mar. 1995), pp. 412-418. |
Mangelsdorf, et al., “Nuclear receptor that identifies a novel retinoic acid response pathway”, Nature, vol. 345, 17 (May 1990), pp. 224-229. |
Umesono, et al., “Retinoic acid and thyroid hormone induce gene expression through a common responsive element”,Nature, vol. 336, 17 (Nov. 1988), pp. 262-265. |
Nagpal, et al., “Separation of Transactivation and AP1 Antagonism Functions of Retinoic Acid Receptor α”, The Journal of Biological Chemistry, vol. 270, No. 2 (Jan. 1995), pp. 923-927. |
Ferrara, et al., “Highly Potent Transcriptional Activation by 16-ene Derivatives of 1,25-Dihydroxyvitamin D3,” The Journal of Biological Chemistry, vol. 269, No. 4 (Jan. 28, 1994), pp .2971-2981. |
Allegretto, et al., “Transactivation Properties of Retinoic Acid and Retinoid X Receptors in Mammalian Cells and Yeast”, The Journal of Biological Chemistry, vol. 268, No. 35 (Dec. 15, 1993), pp. 26625-26633. |
Allan, et al., “Hormone and Antihormone Induce Distinct Conformational Changes which Are Central to Steroid Receptor Activation,” The Journal of Biological Chemistry, vol. 267, No. 27 (Sep. 25, 1992), pp. 19513-19520. |
Gruapner, et al., “6′-Substituted Naphthalene-2-Carboxylic Acid Analogs, A New Class of Retinoic Acid Receptor Subtype-Specific Ligands,” Biochemical and Biophysical Research Communications, vol. 179, No. 3 (Sep. 30, 1991), pp. 54-1561. |
Cheng, et al., “Relationship Between the Inhibition Constant (Kt) and the Concentration of Inhibitor which Causes 50 Per Cent Inhibition (I50) of an Enzymatic Reaction,” Biochemical Pharmacology, vol. 22, pp. 3099-3108. |
Agarwal, et al., “Immortalization by Human Papillomavirus Type 16 Alters Retinoid Regulation of Human Ectocervical Epithelial Cell Differentiation,” Cancer Research, 51, pp. 3982-3989, 1991. |
Agarwal, et al., “Interferon and Retinoic Acid Suppress the Growth of Human Papillomavirus Type 16 Immortalized Cervical Epithelial Cells . . . ” Cancer Research, 54, pp .2108-2112, 1994. |
Hembree, et al., “Epidermal Growth Factor Suppresses Insulin-like Growth Factor Binding Protein 3 Levels in Human Papillomavirus Type 16-immortalized Cervical Epithelial Cells . . . ,” Cancer Research, 54, pp. 3160-3166, 1994. |
Ellis, et al., “Replacement of Insulin Receptopr Tyrosine Residues 1162 and 1163 Compromises Insulin-Stimulated Kinase Activity and Uptake of 2-Deoxyglucose,” Cell, vol. 45 (Jun. 6, 1986), pp. 721-732. |
Klein-Hitpab, et al., “An Estrogen-Responsive Element Derived from the 5′ Flanking Region of the Xenopus Vitellogenin A2 Gene Functions in Transfected Human Cells,” Cell, vol. 46 (Sep. 26, 1986), pp. 1053-1061. |
Hollenberg, et al., “Multiple and Cooperative Trans-Activation Domains of the Human Glucocorticoid Receptor,” Cell, vol. 55 (Dec. 2, 1988), pp. 899-906. |
Heyman, et al., “9-Cis Retinoic Acid Is a High Affinity Ligand for the Retinoid X Receptor,” Cell, vol. 68 (Jan. 24, 1992), pp. 397-406. |
Nicholson, et al., “Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP1 binding site,” The EMBO Journal, vol. 9, No. 13 (1990), pp. 4443-4454. |
Nagpal, et al., “RARs and RXRs: evidence for two autonomous transactivation functions (AF-1 and AF-2) and heterodimeration in vivo,” The EMBO Journal, vol. 12, No. 6 (1993), pp. 2349-2360. |
Pfahl, Magnus, “Nuclear Receptor/AP-1 Interaction,” Endocrine Reviews, vol. 14, No. 5 (1993), p. 651-658. |
Wilkinson, et al., “Expression pattern of two related cystic fibrosis-associated calcium-binding proteins in normal and abnormal tissues,” Journal of Cell Science, 91 (1988), pp. 221-230. |
Andretta-Van Leyen, et al., “Regulation of Insulin-Like Growth Facto 1 Binding Protein 3 Levels by Epidermal Growth Factor and Retinoic Acid in Cervical Epithelial Cells,” Journal of Cellular Physiology, 160:265-274, 1994. |
Lippman, et al, “13-Cis-Retinoic Acid Plus Interferon α-2a: Highly Active Systemic Therapy for Squamous Cell Carcinoma of the Cervix,” vol. 84, No. 4 (Feb. 19, 1992), pp. 241-245. |
Keidel, et al., “Different Agonist- and Antagonist-Induced Conformational Changes in Retinoic Acid Receptors Analyzed by Protease Mapping,” Molecular and Cellular Biology, vol. 14, No. 1 (Jan. 1994), pp. 287-298. |
Luckow, et al., “CAT constructions with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatory elements,” Nucleic Acids Research, vol. 15, No. 13 (1987), p. 5490. |
Felgner, et al., “Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure,” Proc. Natl. Acad. Sci. USA, vol. 84 (Nov. 1987), pp. 7413-7417. |
Moore, et al., “Retinoic Acid and Interferon in Human Cancer: Mechanistic and Clinical Studies,” Seminars in Hematology, vol. 31, No. 4, Suppl 5 (Oct. 1994), pp .31-37. |
Graham, et al., “Phase II Trial of β-All-trans-Retinoic Acid for Cervical Intraepithelial Neoplasia Delivered via a Collagen Sponge and Cervical Cap,” The Western Journal of Medicine, vol. 145, No. 2 (Aug. 1986), pp. 192-195. |
Kurlandsky, et al., “Activation of Gene Transcription by Retinol (Vitamin A) Requires Metabolic Conversion to Retinoic Acid and is Mediated by Nuclear Retinoic Acid . . . ,” The Journal of Investigative Dermtology, vol. 102, No. 4 (Apr. 1994), SID Abstracts, 611, p. 625. |
Tahcher, et al., “Retinoids Block Induction of MRP8 During Cultured Keratinocyte Differentiation,” The Journal of Investigative Dermatology, vol. 104 (Apr. 1995), Abstracts, 237, p. 594. |
Chen et al., “A transcriptional co-repressor that interacts with nuclear hormone receptors,” Nature, vol. 377, 5 (Oct. 1995), pp. 454-457. |
Bergmann et al., Synthesis and Antihypertensive Activity, J. Med. Chem., vol. 33, No. 2, pp. 492-504. |
Database WPI, Section CH, Week 9416, Derwent Publications Ltd. London, GB; Class B05, AN 94-128759 and JP 6078266A, see English language abstract in Derwent. |